The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: gemcitabine     Quarter: 2016Q3

Total Records: 1,060     Number of Pages: 53

DRUGNAME PT EventCount
GEMCITABINE Weight decreased 7
GEMCITABINE HYDROCHLORIDE. Acute lymphocytic leukaemia 7
GEMCITABINE HYDROCHLORIDE. CD4 lymphocytes decreased 7
GEMCITABINE HYDROCHLORIDE. Confusional state 7
GEMCITABINE HYDROCHLORIDE. Decreased appetite 7
GEMCITABINE HYDROCHLORIDE. Enteritis 7
GEMCITABINE HYDROCHLORIDE. Febrile neutropenia 7
GEMCITABINE HYDROCHLORIDE. Myalgia 7
GEMCITABINE HYDROCHLORIDE. Pulmonary embolism 7
GEMCITABINE HYDROCHLORIDE. Urinary retention 7
GEMCITABINE/GEMCITABINE HYDROCHLORIDE Drug ineffective 7
GEMCITABINE/GEMCITABINE HYDROCHLORIDE Neutropenia 7
GEMCITABINE Biliary sepsis 6
GEMCITABINE Blood alkaline phosphatase increased 6
GEMCITABINE Body temperature increased 6
GEMCITABINE Carbohydrate antigen 19-9 increased 6
GEMCITABINE Cardiac failure congestive 6
GEMCITABINE Cerebrovascular accident 6
GEMCITABINE Gastroenteritis 6
GEMCITABINE Headache 6

Total Records: 1,060     Number of Pages: 53